📊 AVHHL Key Takeaways
Investment Thesis
AVITA Medical exhibits severe financial distress with negative stockholders' equity of -$16.6M, negative operating cash flow of -$31.2M, and liabilities exceeding assets by $16.6M. Despite strong gross margins of 82.1%, the company burns cash rapidly with operating losses of -$42.5M on just $71.6M in revenue, indicating fundamental business model challenges that extend beyond product-level economics.
AVHHL Strengths
- Exceptional gross margin of 82.1% demonstrates strong product pricing power and production efficiency
- Modest revenue growth of 1.0% YoY shows market traction despite operational challenges
- Zero long-term debt provides flexibility and eliminates refinancing risk in near term
AVHHL Risks
- Negative stockholders' equity of -$16.6M indicates technical insolvency and heightened bankruptcy risk
- Severe cash burn of -$31.2M in operating cash flow with only $10.2M cash on hand provides minimal runway
- Operating margin of -59.4% and net margin of -67.8% reveal massive operating losses that far exceed revenue generation capacity
- Current ratio of 0.57x indicates immediate liquidity crisis with liabilities exceeding current assets
- Free cash flow of -$32.2M demonstrates the company is not self-sustaining and dependent on external financing
Key Metrics to Watch
- Cash runway and timeline to funding crisis given current burn rate
- Path to operating profitability and achievement of positive operating cash flow
- Revenue growth acceleration and ability to scale without proportional cost increases
- Stockholders' equity recovery and return to positive net worth
AVHHL Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
AVHHL Profitability Ratios
AVHHL vs Healthcare Sector
How AVITA Medical, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
AVHHL Balance Sheet & Liquidity
AVHHL 5-Year Financial Trend
5-Year Trend Summary: AVITA Medical, Inc.'s revenue has grown significantly by 11% over the 5-year period, indicating strong business expansion. The most recent EPS of $-2.39 indicates the company is currently unprofitable.
AVHHL Growth Metrics (YoY)
AVHHL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $16.9M | -$13.2M | $-0.46 |
| Q2 2025 | $15.2M | -$9.9M | $-0.38 |
| Q1 2025 | $11.1M | -$13.9M | $-0.53 |
| Q3 2024 | $13.6M | -$8.7M | $-0.34 |
| Q2 2024 | $11.8M | -$10.4M | $-0.41 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AVHHL Capital Allocation
AVHHL SEC Filings
Access official SEC EDGAR filings for AVITA Medical, Inc. (CIK: 0001762303)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AVHHL
What is the AI rating for AVHHL?
AVITA Medical, Inc. (AVHHL) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are AVHHL's key strengths?
Exceptional gross margin of 82.1% demonstrates strong product pricing power and production efficiency. Modest revenue growth of 1.0% YoY shows market traction despite operational challenges.
What are the risks of investing in AVHHL?
Negative stockholders' equity of -$16.6M indicates technical insolvency and heightened bankruptcy risk. Severe cash burn of -$31.2M in operating cash flow with only $10.2M cash on hand provides minimal runway.
What is AVHHL's revenue and growth?
AVITA Medical, Inc. reported revenue of $71.6M.
Does AVHHL pay dividends?
AVITA Medical, Inc. does not currently pay dividends.
Where can I find AVHHL SEC filings?
Official SEC filings for AVITA Medical, Inc. (CIK: 0001762303) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AVHHL's EPS?
AVITA Medical, Inc. has a diluted EPS of $-1.74.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.